Robert B Slocum, University of Kentucky HealthCare, United States
Patients with Functional Seizures (FS) (also known as Psychogenic Non-Epileptic Seizures (PNES), have involuntary paroxysmal episodes that resemble epileptic seizures but without organic etiology. Many patients with FS have a history of sexual, physical, or emotional abuse or oth [....] » Read More
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Vascular contributions to cognitive impairment and dementia (VCID) have high morbidity and mortality, and diabetes is a leading factor for VCID. The signaling mechanisms for diabetes-induced VCID are largely unknown, and the current treatments for VCID are neither very specific n [....] » Read More
Title : How have we eliminated infection: From the bone to brain ?
Thomas J Webster, Interstellar Therapeutics, United States
Implant infection is rising with the U.S. Centers for Disease Control predicting one person every three seconds will die from a bacteria infection by 2050. Nanomedicine is the use of nanomaterials to improve disease prevention, detection, and treatment which has resulted in hundr [....] » Read More
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Introduction/Objective: Primary Angiitis of the Central Nervous System (PACNS) is rare and causes inflammation of the small and medium vessels of the brain, leptomeninges and spinal cord. We present a case of PACNS, demonstrate the diagnostic challenges, and appreciate outco [....] » Read More
Title : An audit on the assessment and management of osteoporosis in a Parkinson’s and related diseases clinic in Australia
Nethmi Nuwanji Amarasekera, Imperial College London, United Kingdom
Osteoporosis is characterised by low bone mineral density and is associated with minimal trauma fractures. Patients with Parkinson’s disease (PD) and atypical parkinsonian syndromes are at increased risk of falls and should be actively screened and treated for osteoporosis. [....] » Read More
Title : Clinical efficacy analysis of implantable VNS stimulation rehabilitation therapy for the patients with hemiplegia after ischemic stroke
Dawei Zang, Capital Medical University, China
Purpose: Currently there are no effective rehabilitation therapies for the upper limb movement disorders of the patients after ischemic stroke in clinical; it is difficult for these patients to return to society and work. Implantable VNS (Vagus Nerve Stimulation?VNS) is widely us [....] » Read More
Title : Aspartame-induced cognitive dysfunction: Unveiling role of microglia-mediated neuroinflammation and molecular
Waseem Dar, Shiv Nadar University, India
Aspartame, an artificial sweetener, is consumed by millions of people globally. There are multiple reports of aspartame and its metabolites affecting cognitive functions in animal models and humans, which include learning problems, headaches, seizures, migraines, irritable moods, [....] » Read More
Title : The impact of screen exposure on attention capacities in Moroccan schoolchildren: A neurocognitive approach
Zakaria Abidli, International University of Casablanca, Morocco
In all cognitive tasks, attention is crucial for processing and learning information. This study aims to examine the harmful impact of growing screen use among children in Morocco on their attentional capacities and educational outcomes. It provides a neurocognitive perspective t [....] » Read More
Title : Revolutionizing alzheimer's early detection: bridging gaps with multi-modal imaging, AI innovations, and ethical insights
Moufiq Abdulrasoul Hasan, Abdullah Thafer Hospital, Libyan Arab Jamahiriya
Background: Early detection of Alzheimer's disease (AD) is crucial for timely intervention and improved patient outcomes. Despite advancements in neuroimaging and AI, significant gaps remain in the early diagnosis of AD. Aims: This session aims to explore the integration o [....] » Read More
Title : The use of cephalexin to inhibit alpha-synuclein aggregation: A new paradigm in parkinson's disease
Divya Jayam, The Wheatley School, United States
Introduction: Parkinson’s Disease (PD) is characterized by the degeneration of dopaminergic neurons due to the aggregation of a protein named α-Synuclein in the substantia nigra region of the brain. Current therapies for PD do not address this pathology. This paper pr [....] » Read More
Title : “No kicking in the body bag”: Determination of brain death with the aid of nuclear medicine scintigraphy
Waleed Bashir, Inspira Health Network, United States
Background: The gold standard of ancillary imaging in determining brain death is Digital Subtraction Angiography (DSA) of the four cerebral vessels, which boasts a near 100% sensitivity and specificity. However, its use is limited due to its time-intensive nature, need for transf [....] » Read More